ClearPoint Neuro names Ellisa Cholapranee general counsel

ClearPoint Neuro, a global therapy-enabling platform company providing navigation and delivery to the brain, announced that Ellisa Cholapranee will join the company as General Counsel on April 5, 2021. Ms. Cholapranee will report directly to Joe Burnett, ClearPoint Neuro’s Chief Executive Officer, and serve as a member of the Company’s senior leadership team.

Cholapranee brings to the company almost a decade of experience advising companies in the life science and medical device sectors on legal, business, and compliance issues. Before joining the Company, she was Senior Legal Counsel for the cardiovascular devices division at Philips.

Prior to that, Ms. Cholapranee served as Senior Corporate Counsel at MilliporeSigma, a global life science company focused on providing solutions to pharmaceutical companies in every step of the biotech production chain, from research to drug manufacturing. She also has several years’ experience in the corporate and financial services departments of leading law firms in Boston and Chicago, where she counseled clients in the areas of corporate law, public offerings, mergers and acquisitions, and venture capital.

“I am thrilled to join ClearPoint at such an exciting phase of the Company’s growth,” stated Ellisa Cholapranee. “ClearPoint’s technology and team are truly impressive. I look forward to helping build upon the many successes of the Company.”

ClearPoint Neuro names Ellisa Cholapranee general counsel

Leave a Reply

is the international magazine, in English, that covers legal and inhouse affairs in the United States, through experiences beyond Italy’s borders to reach overseas destinations and all over the world.

For more information, visit the Group’s website

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2022 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram